When should we delay highly active antiretroviral therapy?

Research output: Contribution to journalEditorial

40 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)446-448
Number of pages3
JournalJournal of General Internal Medicine
Volume14
Issue number7
DOIs
StatePublished - 1999
Externally publishedYes

Fingerprint

Intravenous Substance Abuse
Anti-HIV Agents
Highly Active Antiretroviral Therapy
Patient Compliance
Combination Drug Therapy
HIV Infections
HIV-1

ASJC Scopus subject areas

  • Internal Medicine

Cite this

When should we delay highly active antiretroviral therapy? / Bangsberg, David; Moss, A.

In: Journal of General Internal Medicine, Vol. 14, No. 7, 1999, p. 446-448.

Research output: Contribution to journalEditorial

@article{0828ac2459fd4aefba27736050381b05,
title = "When should we delay highly active antiretroviral therapy?",
author = "David Bangsberg and A. Moss",
year = "1999",
doi = "10.1046/j.1525-1497.1999.05109.x",
language = "English (US)",
volume = "14",
pages = "446--448",
journal = "Journal of General Internal Medicine",
issn = "0884-8734",
publisher = "Springer New York",
number = "7",

}

TY - JOUR

T1 - When should we delay highly active antiretroviral therapy?

AU - Bangsberg, David

AU - Moss, A.

PY - 1999

Y1 - 1999

UR - http://www.scopus.com/inward/record.url?scp=0032764435&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032764435&partnerID=8YFLogxK

U2 - 10.1046/j.1525-1497.1999.05109.x

DO - 10.1046/j.1525-1497.1999.05109.x

M3 - Editorial

C2 - 10417605

AN - SCOPUS:0032764435

VL - 14

SP - 446

EP - 448

JO - Journal of General Internal Medicine

JF - Journal of General Internal Medicine

SN - 0884-8734

IS - 7

ER -